Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Island Pharmaceuticals Ltd (AU:ILA)
ASX:ILA
ILA Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.05 - AU$0.28
Previous CloseN/A
Volume208.69K
Average Volume (3M)141.17K
Market Cap
AU$25.74M
Enterprise ValueAU$6.28M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.43
Next Earnings
Aug 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding190,631,270
10 Day Avg. Volume132,174
30 Day Avg. Volume141,170
Standard Deviation0.23
R-Squared0.03
Alpha-0.00479
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Island Pharmaceuticals Ltd News
PremiumCompany Announcements
Jason Carroll Increases Stake in Island Pharmaceuticals
PremiumCompany Announcements
Island Pharmaceuticals Quotes New Securities on ASXPremiumCompany Announcements
Island Pharmaceuticals Issues 3 Million Unquoted Equity Securities
PremiumCompany Announcements
Island Pharmaceuticals Announces Director’s Interest Changes
PremiumCompany Announcements
Island Pharmaceuticals Completes Phase 2b Dosing in Dengue Fever Trial
PremiumCompany Announcements
Island Pharmaceuticals Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Island Pharmaceuticals Announces Exercise Instructions for Listed Options
PremiumCompany Announcements
Island Pharmaceuticals Issues New Securities to Boost Market Position---
Options Prices
Currently, No data available
---
Ownership Overview
ILA FAQ
What was Island Pharmaceuticals Ltd’s price range in the past 12 months?
Island Pharmaceuticals Ltd lowest share price was AU$0.05 and its highest was AU$0.28 in the past 12 months.
What is Island Pharmaceuticals Ltd’s market cap?
Island Pharmaceuticals Ltd’s market cap is AU$25.74M.
When is Island Pharmaceuticals Ltd’s upcoming earnings report date?
Island Pharmaceuticals Ltd’s upcoming earnings report date is Aug 21, 2025 which is in 179 days.
How were Island Pharmaceuticals Ltd’s earnings last quarter?
Currently, no data Available
Is Island Pharmaceuticals Ltd overvalued?
According to Wall Street analysts Island Pharmaceuticals Ltd’s price is currently Overvalued.
Does Island Pharmaceuticals Ltd pay dividends?
Island Pharmaceuticals Ltd does not currently pay dividends.
What is Island Pharmaceuticals Ltd’s EPS estimate?
Island Pharmaceuticals Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Island Pharmaceuticals Ltd have?
Island Pharmaceuticals Ltd has 190,631,270 shares outstanding.
What happened to Island Pharmaceuticals Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Island Pharmaceuticals Ltd?
Currently, no hedge funds are holding shares in AU:ILA
---
Island Pharmaceuticals Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ILA Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth AU$118.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
75.32%
12-Months-Change
Fundamentals
Return on Equity
-173.37%
Trailing 12-Months
Asset Growth
25.14%
Trailing 12-Months
Company Description
Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its lead asset ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases.
---
Technical Analysis
Actinogen Medical Limited
―
Biotron Limited
―
Immutep Ltd
―
Recce Pharmaceuticals Ltd.
―
Arovella Therapeutics Limited
―
---